Li and colleagues [54], by using in vivo and in vitro studies, reported that 2-arylthiazolidine-4-carboxylic acid amides has an anti-cancer efficacy by inhibiting the PI3K/AKT/mTOR pathway;. This evidence concerns the gene MTOR and cancer.